Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies

References

• Abdelbary A, El-laithy HM, Tadros MI. (2008). Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharm 357:189–98
   PubMed Web of Science ®Google Scholar
• Abdelbary G, El-gendy N. (2008). Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech 9:740–7
   PubMed Web of Science ®Google Scholar
• Abdelbary GA, Aburahma MH. (2012). Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation. Int J Pharm 422:139–50
   PubMed Web of Science ®Google Scholar
• Agarwal R, Katare OP, Vyas SP. (2001). Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 228:43–52
   PubMed Web of Science ®Google Scholar
• Aggarwal D, Garg A, Kaur IP. (2004). Development of a topical niosomal preparation of acetazolamide: preparation and evaluation. J Pharm Pharmacol 56:1509–17
   PubMed Web of Science ®Google Scholar
• Ahuja Y, Couch SM, Razonable RR, Bakri SJ. (2008). Infectious retinitis: a review. Retinal Physician 102293. Available at: http://www.retinalphysician.com/article.aspx?article=102293
   Google Scholar
• Allam AN, El gamal SS, Naggar VF. (2011). Formulation and evaluation of acyclovir niosomes for ophthalmic use. Asian J Pharm Bio Res 1:28–40
   Google Scholar
• Arunothayanun P, Bernard MS, Craig DQM, et al. (2000). The effect of processing variables on the physical characteristics of nonionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. Int J Pharm 201:7–14
   PubMed Web of Science ®Google Scholar
• Barar J, Javadzadeh AR, Omidi Y. (2008). Ocular novel drug delivery: impacts of membranes and barriers. Expert Opin Drug Deliv 5:567–81
   PubMed Web of Science ®Google Scholar
• Bouwstra JA, vanHal DA, Hofland HEJ, Junginger HE. (1997). Preparation and characterization of nonionic surfactant vesicles. Colloids Surf A Physicochem Eng Asp 123:71–80
   Web of Science ®Google Scholar
• Cocera M, Lopez O, Coderch L, et al. (2003). Permeability investigations of phospholipids liposomes by adding cholesterol. Colloids Surf A: Physicochem Eng Asp 221:9–17
   Web of Science ®Google Scholar
• Colo DG, Burgalassi S, Chetoni P, et al. (2001). Gel-forming erodible inserts for ocular controlled delivery of ofloxacin. Int J Pharm 215:101–11
   PubMed Web of Science ®Google Scholar
• Demirel M, Genc L. (2015). Studies on polymeric and lipid nanoparticles of ketoconazole for ocular administration. Latin American J Pharm 34:853–61
   Web of Science ®Google Scholar
• El-Laithy HM, Shoukry O, Mahran LG. (2011). Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm 77:43–55
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. 1993. Liposome technology. 2nd ed. Boca Raton, FL: CRC Press
   Google Scholar
• Guinedi AS, Mortada ND, Mansour S, Hathout RM. (2005). Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 306:71–82
   PubMed Web of Science ®Google Scholar
• Gupta A, Prajapati SK, Balamurugan M, et al. (2007). Design and development of a proniosomal transdermal drug delivery system for captopril. Trop J Pharm Res 6:687–93
   Web of Science ®Google Scholar
• Hao Y, Zhao F, Li N, et al. (2002). Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 244:73–80
   PubMed Web of Science ®Google Scholar
• Hathout RM, Mansour S, Mortada ND, Guinedi AS. (2007). Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech 8:E1–E12
   PubMed Web of Science ®Google Scholar
• Hecht G. 2001. Ophthalmic preparations; In: Gennaro, AR., ed. Remington: the science and practice of pharmacy. USA: Lipincott Williams and Wilkins, 821–83
   Google Scholar
• Hu C, Rhodes DG. (2000). Proniosomes: a novel drug carrier preparation. Int J Pharm 206:110–22
   PubMed Web of Science ®Google Scholar
• Ibrahim MM, Sammour OA, Hammad MA, Megrab NA. (2008). In vitro evaluation of proniosomes as a drug carrier for flurbiprofen. AAPS PharmSciTech 9:782–90
   PubMed Web of Science ®Google Scholar
• Junyaprasert VB, Manwiwattanakul G. (2008). Release profile comparison and stability of diltiazem-resin microcapsules in sustained release suspensions. Int J Pharm 352:81–91
   PubMed Web of Science ®Google Scholar
• Kakkar S, Karuppayil SM, Raut JS, et al. (2015). Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole. Int J Pharm 495:276–89
   PubMed Web of Science ®Google Scholar
• Kassem MA, Abdel Rahman AA, Ghorab MM, et al. (2007). Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm 340:126–33
   PubMed Web of Science ®Google Scholar
• Kaur IP, Garg A, Singla AK, Aggarwal D. (2004). Vesicular systems in ocular drug delivery: an overview. Int J Pharm 269:1–14
   PubMed Web of Science ®Google Scholar
• Khalil RM, Abdelbary GA, Basha M, et al. (2016). Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCL. J Liposome Res 12:1–12
   Google Scholar
• Kibbe AH. (Ed.). (2000). Handbook of pharmaceutical excepients, 3rd ed. Washington, D.C.: American Pharmaceutical Association, 511–14
   Google Scholar
• Kumar GK, Rajeshwarrao P. (2011). Nonionic surfactant vesicular system for effective drug delivery – an overview. Acta Pharmaceutica Sinica B 1:208–19
   Web of Science ®Google Scholar
• Lawrence MJ, Chauhan S, Lawrence SM, Barlow DJ. (1996). The formation, characterization and stability of nonionic surfactant vesicles. STP Pharma Sci 1:49–60
   Google Scholar
• Lee VHL, Robinson JR. (1986). Topical ocular drug delivery: recent developments and future challenges. J Ocul Pharmacol 2:67–10
   PubMedGoogle Scholar
• Li Q, Li Z, Zeng w, et al. (2014). Proniosome derived niosomes for tacrolimus topical ocular deivery: in vitro cornea permeation, ocular irritation and in vivo antiallograft rejection. Eur J Pharm Res 62:115–23
   Google Scholar
• Maestrelli F, Gonzalez-Rodriguez ML, Rabasco AM, Mura P. (2005). Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery. Int J Pharm 298:55–67
   PubMed Web of Science ®Google Scholar
• Manosroi A, Wongtrakul P, Manosroi J, et al. (2003). Characterization of vesicles prepared with various nonionic surfactants mixed with cholesterol. Colloids Surf B 30:129–38
   Web of Science ®Google Scholar
• Mishra A, Kapoor A, Bhargava S. (2012). Proniosomal gel as a carrier for transdermal drug delivery of clotrimazole. Int J Pharm Sci 4:610–14
   Google Scholar
• Moghimi SM, Hunter AC. (2000). Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends Biotechnol 18:412–20
   PubMed Web of Science ®Google Scholar
• Mohammed AR, Perrie Y. (2005). Liposome solutions for poorly soluble drugs. Drug Delivery Report Autumn/Winter 74–6
   Google Scholar
• Mokhtar M, Sammour OA, Hammad MA, Megrab NA. (2008). Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361:104–11
   PubMed Web of Science ®Google Scholar
• O’Brien TP. (1999). Therapy of ocular fungal infections. Ophthalmol Clin North Am 12:33–50
   Google Scholar
• Pardakhaty A, Varshosaz J, Rouholamini A. (2007). In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 328:130–40
   PubMed Web of Science ®Google Scholar
• Paul S, Ranjit M, Ranjit S, Maiti S. (2010). Antiglaucomatic niosomal system: recent trend in ocular drug delivery research. Int J Pharm Pharm Sci 2:15–28
   Google Scholar
• Prabhu P, Marina K, Vijaynarayan K. (2010). Preparation and evaluation of niosomes of brimonidine tartarate as ocular drug delivery system. J Pharma Res Health Care 2:293–301
   Google Scholar
• Rawat AS, Kumar MS, Khurana B, Mahadevan N. (2011). Proniosomal gel: a novel topical delivery system. Int J Recent Adv Pharm Res 3:1–10
   Google Scholar
• Therese KL, Bagyalakshmi R, Madhavan HN. (2006). In vitro susceptibility testing by agar dilution method to determine the minimum inhibitory concentrations of amphotericin B, fluconazole, and ketoconazole against ocular fungal isolates. Ind J Med Microbiol 24:273–9
   PubMedGoogle Scholar
• Topalkara A, Guler C, Arici DS, Arici MK. (2000). Adverse effects of topical antiglaucoma drugs on the ocular surface. Clin Exp Ophthalmol 28:113–17
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Florence AT. (1995). Nonionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Colloid Interface Sci 58:1–55
   Web of Science ®Google Scholar
• Uchegbu IF, Vyas SP. (1998). Nonionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 172:33–70
   Web of Science ®Google Scholar
• Vora B, Khopade AJ, Jain NK. (1998). Proniosome based transdermal delivery of levonorgestrel for effective contraception. J Control Release 54:149–65
   PubMed Web of Science ®Google Scholar
• Weiner AL. (1994). Liposomes for protein delivery: selecting manufacture and development processes. Immunomethods 4:201–9
   PubMedGoogle Scholar
• Wissing SA, Kayser O, Muller RH. (2004). Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 56:1257–72
   PubMed Web of Science ®Google Scholar
• Wu G, Majewski J, Ege C, Kjaer K, et al. (2004). Lipid corralling and poloxamer squeeze-out in membranes. Phys Rev Lett 93:28–101
   Web of Science ®Google Scholar
• Yasam VR, Jakki SL, Natarajan J, Kupusamy G. (2014). A review on novel vesicular drug delivery: proniosomes. Drug Deliv 21:243–9
   PubMed Web of Science ®Google Scholar
• Yoncheva K, Lizarraga E, Irache JM. (2005). Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties. Eur J Pharm Sci 24:411–19
   PubMed Web of Science ®Google Scholar
• Yoshioka T, Sternberg B, Florence AT. (1994). Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and sorbitan triester (Span 85). Int J Pharm 105:1–6
   Web of Science ®Google Scholar
• Zhang J, Wang L, Gao C, et al. (2008). Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl-cyclodextrin to rabbits. J Ocular Pharmacol Ther 24:501–6
   PubMed Web of Science ®Google Scholar